Biomarkers as Surrogate Endpoints: Ongoing Opportunities for Validation.

Journal Article (Journal Article)

Surrogate endpoints are a common application of biomarkers to estimate clinical benefit in clinical trials, despite questions about reliability. This article discusses ongoing opportunities for their validation, in the context of a regulatory environment in which they are increasingly championed.

Full Text

Duke Authors

Cited Authors

  • Zhang, AD; Ross, JS

Published Date

  • September 2019

Published In

Volume / Issue

  • 47 / 3

Start / End Page

  • 393 - 395

PubMed ID

  • 31560627

Electronic International Standard Serial Number (EISSN)

  • 1748-720X

International Standard Serial Number (ISSN)

  • 1073-1105

Digital Object Identifier (DOI)

  • 10.1177/1073110519876170


  • eng